The emergence of rare clinical aspergillus species in Qatar: Molecular characterization and antifungal susceptibility profiles

Keyphrases

• Molecular Characterization 100%
• Aspergillus Species 100%
• Antifungal Susceptibility 100%
• Qatar 100%
• Aspergillus 80%
• Immunocompromised Patients 40%
• Cryptic Species 40%
• Clinical Specimens 40%
• Fungal Rhinosinusitis 40%
• Cystic Fibrosis 20%
• Clinical Conditions 20%
• Antifungal Drugs 20%
• Invasive Aspergillosis 20%
• Aspergillosis 20%
• Fumigatus 20%
• Antifungal Therapy 20%
• Itraconazole 20%
• Molecular Methods 20%
• Accurate Identification 20%
• Echinocandins 20%
• β-tubulin Gene 20%
• Allergic Reaction 20%
• General Hospital 20%
• MIC Values 20%
• Bronchiolitis 20%
• Calmodulin Gene 20%
• Molecular Sequencing 20%
• Clinical Standards 20%
• Aspergillus Strains 20%
• Bronchopulmonary Infection 20%
• Human Clinical Specimen 20%
• Laboratory Standards 20%
• Doha 20%
• Further Analysis 20%
• Lower Respiratory Infections 20%
• Aspergillus Fumigates 20%
• Aspergillus Welwitschiae 20%

Pharmacology, Toxicology and Pharmaceutical Science

• Antifungal Agent 100%
• Aspergillus 100%
• Fungal Sinusitis 22%
• Respiratory Tract Infection 22%
• Antifungal Therapy 11%
• Itraconazole 11%
• Aspergillus fumigatus 11%
• Cystic Fibrosis 11%
• Tubulin 11%
• Mould 11%
• Invasive Aspergillosis 11%
• Allergic Reaction 11%
• Bronchitis 11%
• Immunocompromised Patient 11%
• Aspergillosis 11%
• Calmodulin 11%
• Echinocandin 11%

Immunology and Microbiology

• Aspergillus 100%
• Antifungal Susceptibility 100%
• Minimum Inhibitory Concentration 33%
• Mould 11%
• Hypersensitive Response 11%
• Aspergillus fumigatus 11%
• Immunocompromised Patient 11%
• Wild Type 11%
• Acute Bronchitis 11%